The following is a summary of “Oncologic outcomes of retroperitoneal lymph node dissection following first-line chemotherapy for metastatic non-seminomatous germ cell tumors” published in the March 2025 issue of Annals of Oncology by Matulewicz et al. Post-chemotherapy retroperitoneal lymph node dissection (pcRPLND) remains a cornerstone of multimodal treatment for patients with metastatic non-seminomatous germ cell […]
The post Refining Surgical Indications for Post-Chemotherapy RPLND in NSGCT first appeared on Physician’s Weekly.
